Get notified when SEM files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Risk Profile Improvements

  • Delisting (new) — Company requested NYSE delisting following merger completion, which will result in deregistration and suspension of SEC reporting obligations.
NYSE: SEM SELECT MEDICAL HOLDINGS CORP 8-K

Select Medical completes $3.9B going-private buyout at $16.50/share; delists from NYSE

Filed July 1, 2026 · Period ending June 30, 2026 · ~1 min read

Key Changes

  • high

    Management-led consortium (Executive Chairman Ortenzio, SVP Jackson, and WCAS) acquired Select Medical for $16.50/share cash, an 18% premium to unaffected price and 25% to 90-day VWAP, valuing the company at ~$3.9B.

    Exhibit 99.1 verify on EDGAR →
  • high

    Common stock ceased trading and delisted from NYSE effective July 1, 2026; company transitions to private ownership with consortium holding majority economic interest and operational control.

    Item 3.01 verify on EDGAR →
  • high

    Seven directors departed upon merger close; board reconstituted with three members (Russell Carson, David Chernow, Robert Ortenzio). Departures were transaction-related, not due to disagreements.

    Item 5.02 verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (NAVN 10-Q) is open in full — no account needed.

Partner

Trade SEM commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · Jul 2, 2026 12:25 AM